Distinguished Faculty of Science Professor Albert Heck has been awarded a prestigious ERC Advanced Grant. The 2.5 million Euro grant enables Heck’s team to develop cutting-edge techniques to gain a fundamentally deeper understanding of our immune system.
The consortium of researchers will, for the first time, comprehensively chart the supervision of specific proteins within the cell, from cradle to grave.
Utrecht University makes significant investments in mass spectrometry and proteomics infrastructure. The new infrastructure underscores the university’s pioneering and leading role in these scientific fields.
By modifying and boosting lab equipment, a team of chemists are able to measure individual molecules with unprecedented precision. Their massive resolution upgrading will benefit the fabrication of vaccines and molecular vectors used in gene therapy.
Utrecht University has appointed Christian Kaiser as professor of Biophysical Chemistry of Membranes and Proteins. Kaiser and his team will explore the way biological proteins are produced, processed and transported in the cell.
Today marks the official launch of the Oncode Accelerator programme, in which 30 public and private partners collaborate to develop new cancer treatments. Patient-centered development and innovation are at the core of this initiative.
A new powerful antibiotic, isolated from bacteria that could not be studied before, seems capable to combat harmful bacteria and even multi-resistant ‘superbugs’. The antibiotic appears to kill bacteria in an unusual way, making it more difficult for bacteria to develop any resistance against it.